Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M325Revenue $M0.5Net Margin (%)--Altman Z-Score19.7
Enterprise Value $M257EPS $-0.2Operating Margin %--Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)--Higher ROA y-yY
Price/Book4.910-y EBITDA Growth Rate %-3.9Quick Ratio13.0Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-10.9Current Ratio13.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-36.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-43.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M82.0ROIC % (ttm)-2,123.9Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CPRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MUTH DAVID DEVP, Chief Commercial Officer 2015-05-01Buy1,700$3.223.75 view
O'Keeffe Charles BDirector 2015-04-30Buy10,000$3.2920.36 view
DENKHAUS DONALD ADirector 2015-04-30Buy5,000$3.2521.85 view
MUTH DAVID DEVP, Chief Commercial Officer 2015-04-28Buy2,000$3.5511.55 view
MCENANY PATRICK JPresident and CEO 2015-04-27Buy5,000$3.794.49 view
DENKHAUS DONALD ADirector 2015-04-27Buy15,000$3.716.74 view
O'Keeffe Charles BDirector 2015-04-24Buy5,000$3.84.21 view
DENKHAUS DONALD ADirector 2015-03-27Buy5,000$4.17-5.04 view
MUTH DAVID DEVP, Chief Commercial Officer 2015-01-20Buy21,000$2.9633.78 view
O'Keeffe Charles BDirector 2015-01-13Buy10,000$332 view

Press Releases about CPRX :

    Quarterly/Annual Reports about CPRX:

    News about CPRX:

    Articles On GuruFocus.com
    Piper Jaffray Remains Bullish on Catalyst Pharmaceuticals Following the Close of its Recent Public O Feb 17 2015 
    Weekly CEO Buys Highlight: BH, CLMS, OPK, GPC, CPRX Jan 18 2015 
    Weekly CEO Buys Highlight: BH, CLMS, OPK, CPRX, BRT Jan 12 2015 
    Largest Insider Buys of the Week Oct 25 2013 
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN Jun 04 2012 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 15 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Aug 12 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 9,359 Shares Jun 16 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) May 17 2010 

    More From Other Websites
    CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... May 22 2015
    CATALYST PHARMACEUTICAL PARTNERS, INC. Financials May 20 2015
    10-Q for Catalyst Pharmaceutical Partners, Inc. May 13 2015
    Catalyst Pharmaceutical's Q1 Loss Narrower than Expected - Analyst Blog May 12 2015
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... May 12 2015
    Catalyst Pharmaceuticals Announces First Quarter 2015 Financial Results and Provides Corporate... May 11 2015
    Catalyst Pharmaceuticals Announces First Quarter 2015 Financial Results and Provides Corporate... May 11 2015
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report May 11 2015
    Q1 2015 Catalyst Pharmaceutical Partners Inc Earnings Release - After Market Close May 11 2015
    Can Catalyst Pharmaceutical Surprise this Earnings Season? - Analyst Blog May 08 2015
    10-K for Catalyst Pharmaceutical Partners, Inc. May 05 2015
    Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference... May 04 2015
    Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference... May 04 2015
    Catalyst Pharma Competitor Surprises With Positive Orphan Disease Drug Study Results Apr 24 2015
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Apr 14 2015
    Catalyst Pharmaceuticals Announces Oral Presentation of Firdapse Phase 3 Trial Data at American... Apr 14 2015
    Catalyst Pharmaceuticals Announces Oral Presentation of Firdapse Phase 3 Trial Data at American... Apr 14 2015
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive... Mar 27 2015
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events Mar 19 2015
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Mar 16 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK